Cargando…

A Systematic Review and Meta-Analysis of Anti-Rheumatic Drugs and Pneumococcal Vaccine Immunogenicity in Inflammatory Arthritis

Background: Pneumococcal pneumonia is an important cause of morbidity and mortality amongst patients with inflammatory arthritis. Vaccination is recommended by the National Institute for Health and Care Excellence (NICE) but it remains unclear how vaccine efficacy is impacted by different immunosupp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagra, Deepak, Bechman, Katie, Adas, Maryam, Yang, Zijing, Alveyn, Edward, Subesinghe, Sujith, Rutherford, Andrew, Allen, Victoria, Patel, Samir, Russell, Mark D., Cope, Andrew, Norton, Sam, Galloway, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674424/ https://www.ncbi.nlm.nih.gov/pubmed/38006012 http://dx.doi.org/10.3390/vaccines11111680

Ejemplares similares

A systematic review and network meta-analysis of the safety of early interventional treatments in rheumatoid arthritis
por: Adas, Maryam A, et al.
Publicado: (2021)

A large two-centre study in to rates of influenza and pneumococcal vaccination and infection burden in rheumatoid arthritis in the UK
por: Subesinghe, Sujith, et al.
Publicado: (2016)

P15 JAKi of all trades
por: Watkins, Clara, et al.
Publicado: (2023)

The infection risks of JAK inhibition
por: Adas, Maryam A., et al.
Publicado: (2021)

IL-6 inhibition in the treatment of COVID-19: A meta-analysis and meta-regression
por: Tharmarajah, Emmanuel, et al.
Publicado: (2021)

Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELY
por: Russell, Mark D, et al.
Publicado: (2022)

OA12 Grimey granulomas of sarcoidosis
por: Nagra, Deepak, et al.
Publicado: (2023)

Real-world evidence for prehospital COVID-19 treatment in systemic autoimmune rheumatic disease
por: Bechman, Katie, et al.
Publicado: (2023)

JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications
por: Russell, Mark D, et al.
Publicado: (2023)

Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics Register
por: Bechman, Katie, et al.
Publicado: (2020)

Corrigendum to: Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics Register
por: Bechman, Katie, et al.
Publicado: (2020)

Mental health, fatigue and function are associated with increased risk of disease flare following TNF inhibitor tapering in patients with rheumatoid arthritis: an exploratory analysis of data from the Optimizing TNF Tapering in RA (OPTTIRA) trial
por: Bechman, Katie, et al.
Publicado: (2018)

2-deoxy-2[(18)F]fluoro-D-glucose positron emission tomography–computed tomography in rheumatological diseases
por: Subesinghe, Manil, et al.
Publicado: (2021)

Diagnosing Camurati–Engelmann disease—the age of whole-exome sequencing
por: Nagra, Deepak, et al.
Publicado: (2022)

The safety of JAK-1 inhibitors
por: Clarke, Benjamin, et al.
Publicado: (2021)

A systematic review of CXCL13 as a biomarker of disease and treatment response in rheumatoid arthritis
por: Bechman, Katie, et al.
Publicado: (2020)

COVID-19 admissions and mortality in patients with early inflammatory arthritis: results from a UK national cohort
por: Adas, Maryam A, et al.
Publicado: (2023)

EP13 A case of candida albicans septic sacroiliitis complicating severe COVID-19 infection
por: Onac, Ioana, et al.
Publicado: (2020)

COVID-19: opacification score is higher in the right lung and right lung involvement is a better predictor of ICU admission
por: Nagra, Deepak, et al.
Publicado: (2020)

Inpatient COVID-19 mortality has reduced over time: Results from an observational cohort
por: Bechman, Katie, et al.
Publicado: (2022)

Management of gout following 2016/2017 European (EULAR) and British (BSR) guidelines: An interrupted time-series analysis in the United Kingdom
por: Russell, Mark D, et al.
Publicado: (2022)

Worse outcomes linked to ethnicity for early inflammatory arthritis in England and Wales: a national cohort study
por: Adas, Maryam A, et al.
Publicado: (2022)

32. My PET investigation
por: Man, Yik Long, et al.
Publicado: (2019)

Diagnostic delay is common for patients with axial spondyloarthritis: results from the National Early Inflammatory Arthritis Audit
por: Russell, Mark D, et al.
Publicado: (2021)

Corrigendum to: Diagnostic delay is common for patients with axial spondyloarthritis: results from the National Early Inflammatory Arthritis Audit
por: Russell, Mark D, et al.
Publicado: (2021)

Treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in England
por: Russell, Mark D, et al.
Publicado: (2022)

Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study
por: Mahil, Satveer K, et al.
Publicado: (2021)

The immunosuppressed traveler: infection risks with autoimmunity and immunosuppression, vaccinations, and general travel advice
por: Allen, Victoria, et al.
Publicado: (2020)

Infection profile of immune-modulatory drugs used in autoimmune diseases: analysis of summary of product characteristic data
por: Dey, Mrinalini, et al.
Publicado: (2022)

Data quality predicts care quality: findings from a national clinical audit
por: Yates, Mark, et al.
Publicado: (2020)

Pneumococcal vaccination in autoimmune rheumatic diseases
por: Rákóczi, Éva, et al.
Publicado: (2017)

The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors
por: Bechman, Katie, et al.
Publicado: (2019)

Corrigendum to “The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors” [Pharmacol. Res. 147 (2019) 104392]
por: Bechman, Katie, et al.
Publicado: (2020)

A Kawasaki-like illness in an adult with recent SARS-CoV-2 infection
por: Nagra, Deepak, et al.
Publicado: (2021)

Signal Transduction Pathways in Chronic Inflammatory Rheumatic Diseases
por: Cope, Andrew P
Publicado: (2012)

Immunogenicity of biologics in inflammatory bowel disease
por: Vermeire, Séverine, et al.
Publicado: (2018)

Systematic Review and Meta-Analysis of the Efficacy and Effectiveness of Pneumococcal Vaccines in Adults
por: Farrar, Jennifer L., et al.
Publicado: (2023)

Dehydroepiandrosterone (DHEA) Supplementation in Rheumatic Diseases: A Systematic Review
por: Skare, Thelma L., et al.
Publicado: (2023)

Comparison of the immunogenicity & protective efficacy of various SARS-CoV-2 vaccine candidates in non-human primates
por: Mukhopadhyay, Labanya, et al.
Publicado: (2021)

Lipidation of Pneumococcal Antigens Leads to Improved Immunogenicity and Protection
por: Voß, Franziska, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ag4acdnjueudch5ckn64c3od61